A controlled trial with vasopressin analogue (DGAW) on cognitive recovery immediately after head trauma

Nicolaas J. Bohnen; Albert Twijnstra; Jellemer Jolles

doi:10.1212/WNL.43.1_Part_1.103

A controlled trial with vasopressin analogue (DGAW) on cognitive recovery immediately after head trauma

Nicolaas J. Bohnen^*, Albert Twijnstra, Jellemer Jolles

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

100 Downloads (Pure)

Abstract

Recent evidence suggests that the vasopressin analogue desglycinamide-arginine8-vasopressin (DGAVP) might specifically benefit mild brain trauma patients. We investigated the effect of intranasal DGAVP treatment in 32 patients who had sustained a mild head injury for 3 months in a double-blind, placebo-controlled, matched-pairs study. DGAVP did not have a positive effect on cognitive recovery in this group of mildly affected patients.

Original language	English
Pages (from-to)	103-106
Number of pages	4
Journal	Neurology
Volume	43
Issue number	1
DOIs	https://doi.org/10.1212/WNL.43.1_Part_1.103
Publication status	Published - 1 Jan 1993

Access to Document

10.1212/WNL.43.1_Part_1.103

Full TextFinal published version, 485 KB

Cite this

@article{16edb924082f46df8463c8cd612e79c3,

title = "A controlled trial with vasopressin analogue (DGAW) on cognitive recovery immediately after head trauma",

abstract = "Recent evidence suggests that the vasopressin analogue desglycinamide-arginine8-vasopressin (DGAVP) might specifically benefit mild brain trauma patients. We investigated the effect of intranasal DGAVP treatment in 32 patients who had sustained a mild head injury for 3 months in a double-blind, placebo-controlled, matched-pairs study. DGAVP did not have a positive effect on cognitive recovery in this group of mildly affected patients.",

author = "Bohnen, {Nicolaas J.} and Albert Twijnstra and Jellemer Jolles",

year = "1993",

month = jan,

day = "1",

doi = "10.1212/WNL.43.1_Part_1.103",

language = "English",

volume = "43",

pages = "103--106",

journal = "Neurology",

issn = "0028-3878",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "1",

}

TY - JOUR

T1 - A controlled trial with vasopressin analogue (DGAW) on cognitive recovery immediately after head trauma

AU - Bohnen, Nicolaas J.

AU - Twijnstra, Albert

AU - Jolles, Jellemer

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Recent evidence suggests that the vasopressin analogue desglycinamide-arginine8-vasopressin (DGAVP) might specifically benefit mild brain trauma patients. We investigated the effect of intranasal DGAVP treatment in 32 patients who had sustained a mild head injury for 3 months in a double-blind, placebo-controlled, matched-pairs study. DGAVP did not have a positive effect on cognitive recovery in this group of mildly affected patients.

AB - Recent evidence suggests that the vasopressin analogue desglycinamide-arginine8-vasopressin (DGAVP) might specifically benefit mild brain trauma patients. We investigated the effect of intranasal DGAVP treatment in 32 patients who had sustained a mild head injury for 3 months in a double-blind, placebo-controlled, matched-pairs study. DGAVP did not have a positive effect on cognitive recovery in this group of mildly affected patients.

U2 - 10.1212/WNL.43.1_Part_1.103

DO - 10.1212/WNL.43.1_Part_1.103

M3 - Article

SN - 0028-3878

VL - 43

SP - 103

EP - 106

JO - Neurology

JF - Neurology

IS - 1

ER -